Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Staudt Website

Louis M. Staudt, M.D., Ph.D.

Selected Publications

1)  Lamy L, Ngo VN, Emre NC, Shaffer AL, Yang Y, Tian E, Nair V, Kruhlak MJ, Zingone A, Landgren O, Staudt LM.
Control of autophagic cell death by caspase-10 in multiple myeloma.
Cancer Cell. 23: 435-49, 2013.
[Journal]
2)  Dunleavy K, Pittaluga S, Maeda LS, Advani R, Chen CC, Hessler J, Steinberg SM, Grant C, Wright G, Varma G, Staudt LM, Jaffe ES, Wilson WH.
Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma.
N. Engl. J. Med. 368: 1408-16, 2013.
[Journal]
3)  Xiao W, Tran B, Staudt LM, Schmitz R.
High-throughput RNA sequencing in B-cell lymphomas.
Methods Mol. Biol. 971: 295-312, 2013.
[Journal]
4)  O'Shea JJ, Holland SM, Staudt LM.
JAKs and STATs in immunity, immunodeficiency, and cancer.
N. Engl. J. Med. 368: 161-70, 2013.
[Journal]
5)  Yeung CL, Ngo VN, Grohar PJ, Arnaldez FI, Asante A, Wan X, Khan J, Hewitt SM, Khanna C, Staudt LM, Helman LJ.
Loss-of-function screen in rhabdomyosarcoma identifies CRKL-YES as a critical signal for tumor growth.
Oncogene. [Epub ahead of print], 2013.
[Journal]
6)  Chiorazzi M, Rui L, Yang Y, Ceribelli M, Tishbi N, Maurer CW, Ranuncolo SM, Zhao H, Xu W, Chan WC, Jaffe ES, Gascoyne RD, Campo E, Rosenwald A, Ott G, Delabie J, Rimsza LM, Shaham S, Staudt LM.
Related F-box proteins control cell death in Caenorhabditis elegans and human lymphoma.
Proc. Natl. Acad. Sci. U.S.A. 110: 3943-8, 2013.
[Journal]
7)  Young RM, Staudt LM.
Targeting pathological B cell receptor signalling in lymphoid malignancies.
Nat Rev Drug Discov. 12: 229-43, 2013.
[Journal]
8)  Lim KH, Staudt LM.
Toll-like receptor signaling.
Cold Spring Harb Perspect Biol. 5: a011247, 2013.
[Journal]
9)  Sanda T, Tyner JW, Gutierrez A, Ngo VN, Glover J, Chang BH, Yost A, Ma W, Fleischman AG, Zhou W, Yang Y, Kleppe M, Ahn Y, Tatarek J, Kelliher MA, Neuberg DS, Levine RL, Moriggl R, Müller M, Gray NS, Jamieson CH, Weng AP, Staudt LM, Druker BJ, Look AT.
TYK2-STAT1-BCL2 Pathway Dependence in T-cell Acute Lymphoblastic Leukemia.
Cancer Discov. [Epub ahead of print], 2013.
[Journal]
10)  Perry AM, Cardesa-Salzmann TM, Meyer PN, Colomo L, Smith LM, Fu K, Greiner TC, Delabie J, Gascoyne RD, Rimsza L, Jaffe ES, Ott G, Rosenwald A, Braziel RM, Tubbs R, Cook JR, Staudt LM, Connors JM, Sehn LH, Vose JM, López-Guillermo A, Campo E, Chan WC, Weisenburger DD.
A new biological prognostic model based on immunohistochemistry predicts survival in patients with diffuse large B-cell lymphoma.
Blood. 120: 2290-6, 2012.
[Journal]
Click Here to View Expanded Bibliography.

This page was last updated on 5/1/2013.